A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (PIPER)
- Status
- RECRUITING
- Phase
- PHASE2
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
- Status
- RECRUITING
- Phase
- PHASE1
A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor
- Status
- COMPLETED
- Phase
- PHASE2
Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
9-ING-41 Plus Retifanlimab and Gemcitabine/Nab-Paclitaxel in Patients With Advanced Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Adavosertib and Gemcitabine in Advanced Pancreatic
- Status
- WITHDRAWN
- Phase
- PHASE2
SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3